Phil Darcy

Phil Darcy

Company: Peter MacCallum Cancer Centre

Job title: Group Leader, Cancer Immunotherapy Laboratory


Dual Blockade of Adenosine and PD-1 Immunosuppression Enhances Chimeric Antigen Receptor T-Cell Therapy 11:45 am

• Highlighting immunosuppression within the tumor microenvironment is a major reason underlying poor responses of CAR T-Cell responses in solid tumors • Showing that dual blockade of adenosine and PD-1 checkpoint pathways significantly enhances CAR T-cell anti-tumor responses in preclinical modelsRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.